Procurement Summary
Country : Slovakia
Summary : Cerliponase Alfa 150 Mg Infusion Solution
Deadline : 10 Apr 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 99860255
Document Ref. No. : 212199-2024
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : EUR 2739583.80
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
The drug cerliponase alfa belongs to a group of drugs known as enzyme replacement therapies.
It is used to treat patients with neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase 1 (TPP1) deficiency.
Document Type: Prior Information Notice
Reference Number: 40-2024
Contract Type: supplies
Estimated Value: 2739583.80 - EUR
Authority Type: body-pl-cga
Doc Title: CERLIPONAZA ALFA 150 MG INFUZNY ROZTOK
Dispatch Date: 2024-04-09
Publish Date: 2024-04-10
Submission Date: 2025-04-10
Documents
Tender Notice